
Eli Lilly to invest another $27 billion in U.S. manufacturing
Investing.com -- On Wednesday, Eli Lilly (NYSE:LLY) announced plans to invest an additional $27 billion in U.S. pharmaceutical manufacturing, bringing its total domestic capital expansion commitments to over $50 billion since 2020. The company revealed it will build four new manufacturing sites this year, creating more than 13,000 jobs across manufacturing and construction.Lilly’s inve ...